Literature DB >> 11721685

Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study.

A Bicigalupo, T Lamparelli, F Gualandi, S Bregante, A Raiola, C di Grazia, A Dominietto, C Romagnani, D Occhini, F Frassoni, M T van Lint.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11721685     DOI： 10.1182/blood.v98.10.3174

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Novel approaches to prevent leukemia relapse following allogeneic hematopoietic cell transplantation.

Authors:  Michael R Verneris; Michael J Burke
Journal:  Curr Hematol Malig Rep       Date:  2010-07       Impact factor: 3.952

Review 2.  In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review.

Authors:  R Oostvogels; S M Uniken Venema; M de Witte; R Raymakers; J Kuball; N Kröger; M C Minnema
Journal:  Bone Marrow Transplant       Date:  2017-07-10       Impact factor: 5.483

Review 3.  High-dose cyclophosphamide for graft-versus-host disease prevention.

Authors:  Leo Luznik; Richard J Jones; Ephraim J Fuchs
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

4.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

Authors:  Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette Kasamon; Steven N Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Journal:  Blood       Date:  2010-02-02       Impact factor: 22.113

Review 5.  High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.

Authors:  Leo Luznik; Ephraim J Fuchs
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

6.  Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

Authors:  Muna Qayed; Tao Wang; Michael T Hemmer; Stephen Spellman; Mukta Arora; Daniel Couriel; Amin Alousi; Joseph Pidala; Hisham Abdel-Azim; Mahmoud Aljurf; Mouhab Ayas; Menachem Bitan; Mitchell Cairo; Sung Won Choi; Christopher Dandoy; David Delgado; Robert Peter Gale; Gregory Hale; Haydar Frangoul; Rammurti T Kamble; Mohamed Kharfan-Dabaja; Leslie Lehman; John Levine; Margaret MacMillan; David I Marks; Taiga Nishihori; Richard F Olsson; Peiman Hematti; Olov Ringden; Ayman Saad; Prakash Satwani; Bipin N Savani; Kirk R Schultz; Sachiko Seo; Shalini Shenoy; Edmund K Waller; Lolie Yu; Mary M Horowitz; John Horan
Journal:  Biol Blood Marrow Transplant       Date:  2017-11-16       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.